Rowlandmiller & PARTNERS.ADV Increases Position in Oracle Co. (NYSE:ORCL)

Rowlandmiller & PARTNERS.ADV increased its position in shares of Oracle Co. (NYSE:ORCL - Free Report) by 48.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,190 shares of the enterprise software provider's stock after buying an additional 2,025 shares during the period. Rowlandmiller & PARTNERS.ADV's holdings in Oracle were worth $865,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. CX Institutional raised its position in shares of Oracle by 4.8% during the 1st quarter. CX Institutional now owns 16,114 shares of the enterprise software provider's stock worth $2,253,000 after acquiring an additional 737 shares in the last quarter. Trueblood Wealth Management LLC raised its holdings in Oracle by 7.5% during the first quarter. Trueblood Wealth Management LLC now owns 13,649 shares of the enterprise software provider's stock worth $1,908,000 after purchasing an additional 953 shares in the last quarter. Atwood & Palmer Inc. lifted its position in shares of Oracle by 8.0% during the 1st quarter. Atwood & Palmer Inc. now owns 3,633 shares of the enterprise software provider's stock worth $508,000 after buying an additional 270 shares during the last quarter. Gibson Capital LLC lifted its position in shares of Oracle by 11.1% during the 1st quarter. Gibson Capital LLC now owns 2,578 shares of the enterprise software provider's stock worth $360,000 after buying an additional 258 shares during the last quarter. Finally, Dividend Assets Capital LLC boosted its holdings in shares of Oracle by 108.1% in the 1st quarter. Dividend Assets Capital LLC now owns 73,145 shares of the enterprise software provider's stock valued at $10,226,000 after buying an additional 38,001 shares in the last quarter. Institutional investors and hedge funds own 42.44% of the company's stock.

Oracle Price Performance

Shares of Oracle stock traded up $25.97 during trading on Thursday, reaching $202.35. The company's stock had a trading volume of 39,967,593 shares, compared to its average volume of 11,057,023. The business has a 50 day moving average price of $149.60 and a 200-day moving average price of $160.36. Oracle Co. has a 12-month low of $118.86 and a 12-month high of $202.45. The company has a market capitalization of $565.96 billion, a P/E ratio of 49.47, a price-to-earnings-growth ratio of 3.46 and a beta of 1.32. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 5.65.

Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. The company had revenue of $15.90 billion for the quarter, compared to analyst estimates of $15.58 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The business's revenue was up 11.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.63 EPS. As a group, sell-side analysts anticipate that Oracle Co. will post 5 EPS for the current year.

Analyst Ratings Changes

ORCL has been the topic of several research analyst reports. Morgan Stanley reiterated a "positive" rating on shares of Oracle in a research note on Monday. Jefferies Financial Group raised their price objective on Oracle from $190.00 to $200.00 and gave the stock a "buy" rating in a report on Monday. Citigroup boosted their target price on Oracle from $160.00 to $186.00 and gave the company a "neutral" rating in a report on Monday. Westpark Capital upped their target price on Oracle from $195.00 to $246.00 and gave the company a "buy" rating in a research report on Thursday. Finally, Monness Crespi & Hardt raised Oracle from a "sell" rating to a "neutral" rating in a research report on Monday, March 3rd. Twelve equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Oracle currently has a consensus rating of "Moderate Buy" and a consensus price target of $192.30.

Insider Activity

In related news, Director Leon E. Panetta sold 17,500 shares of the company's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $151.24, for a total value of $2,646,700.00. Following the sale, the director now owns 58,090 shares of the company's stock, valued at approximately $8,785,531.60. This represents a 23.15% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,000 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total value of $291,620.00. Following the sale, the director now owns 34,630 shares in the company, valued at approximately $5,049,400.30. This trade represents a 5.46% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 27,366 shares of company stock worth $4,015,723. Company insiders own 42.20% of the company's stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.